Cohort Company News - MedTech Innovator

Avenda Health Receives $3.3 Million Investment

DateApr 11 2018

Avenda Health Inc., a biomedical device company based in Santa Monica, has closed a funding round of $3.3 million, according to a securities filing released April 11. The company founded by a two Ph.Ds and an MD from UCLA sold $3,325,000 in securities to 18 investors, according to the Securities and Exchange Commission filing.

Johnson & Johnson acquires C-SATS, a University of Washington spinout that grades surgeons

DateApr 05 2018

Johnson & Johnson today announced the acquisition of C-SATS, a Seattle startup that uses technology to facilitate performance reviews for surgeons. Founded in 2014 and spun out of the University of Washington, C-SATS built a cloud-based performance management system that evaluates surgeons and helps improve their skills.

Congestive heart failure device dev Alleviant Medical raises $1m

DateMar 30 2018

Alleviant Medical has raised $1.1 million in a new round of debt and options financing, according to an SEC filing posted this week. Money in the round came from 15 unnamed sources, according to the SEC filing, with the first sale recorded on December 19 last year.

2Morrow adds chronic pain management to its mobile behavior therapy offerings

DateFeb 22 2018

As opioid abuse continues to make impact in the US, more and more tech-driven answers to the drug crisis are springing up that aim to reduce patients’ reliance on prescription opioids. Just yesterday, behavioral health therapy app maker 2Morrow threw its hat into the ring with the announcement that its services now include a digital chronic pain management program.

FDA clears Access Vascular’s HydroPICC catheter

DateFeb 22 2018

Access Vascular said today that its HydroPICC catheter has won 510(k) clearance from the FDA. The peripherally-inserted central catheter is designed with Access Vascular’s proprietary bulk-hydrophilic material, which the company touted as “the ideal material for long-term implantable vascular access devices.”

SafeHeal Starts First-in-Human and CE-Mark Clinical Study of Endoluminal Bypass Sheath

DateFeb 22 2018

SafeHeal, developer of the Colovac device, has enrolled the first five patients in its CE mark study. The Colovac device is a unique endoluminal bypass sheath placed in the colon following rectal resection, aimed at significantly improving the recovery of patients after colorectal surgery without the need for an ostomy.

PharmaJet, Genexine Partner for DNA Vaccines

DateFeb 21 2018

PharmaJet has entered a global license agreement with Genexine for the development and commercialization of DNA vaccines for human applications using the PharmaJet needle-free injection systems.

Google Developers Launchpad Studio welcomes more machine learning healthcare startups

DateFeb 14 2018

We're excited to announce the three new startups joining Launchpad Studio, our 6-month mentorship program tailored to help applied-machine learning startups build great products using the most advanced tools and technologies available.

Zenflow raises $31m in Series A

DateFeb 07 2018

Urology medical device maker Zenflow said today it closed a $31.4 million Series A round of financing to support the development of minimally invasive devices designed to treat obstructive urinary symptoms related to benign prostatic hyperplasia.

MedAware Systems Launches Comprehensive Apheresis Research Database

DateJan 31 2018

Broomfield, CO, January 31, 2018 --(PR.com)-- MedAware Systems, Inc. announced today it is launching the world’s most comprehensive database of evidence on Apheresis, available through its SOHInfo™ division. Data have been meticulously extracted from over 2,300 clinical trials, cohort studies, registries, reviews and other published works, spanning medical journals worldwide.

Linear Health Sciences Announces Issuance of First US Patent

DateJan 24 2018

Linear Health Sciences today announced that the United States Patent and Trademark Office has issued the company's first patent related to its flagship product, the Orchid Safety Release Valve™, a patient safety device designed to help prevent intravenous (IV) catheter dislodgement. US Patent No. 9,861,805 B2 covers wide-ranging claims behind the tension-activated safety release valve for use in medical access devices such as IV catheters.

Adhesys Medical gets CE mark for its topical skin adhesive for surgical use

DateJan 22 2018

Adhesys Medical, a surgical adhesive company, said it has received a CE mark for its Mar-Cutis Flix topical skin adhesive for surgical use. The adhesive is a polyurethane-based technology the company said is an innovative alternative to traditional wound closing techniques that features bonding strength, fast sealing and high flexibility.

Day Zero Diagnostics: New Diagnostic Rapidly Identifies The Resistance Profile of Bacteria, Enabling Targeted Therapy Sooner

DateJan 17 2018

At the 2017 meeting of AdvaMed, the medical device industry’s advocacy organization, young start-up Day Zero Diagnostics was chosen as this year’s MedTech Innovator Global Competition winner.

Taglich Brothers Initiates Nexeon Medsystems Inc.

DateJan 16 2018

Nexeon MedSystems Inc., headquartered in Dallas, Texas, is a medical device company developing a neurostimulator technology platform for the treatment of disorders through the electrical stimulation of neural tissues. The company’s first application of its Nexeon Neurostimulation System will be for the treatment of chronic medical conditions such as Parkinson’s and associated diseases in Europe.

Accenture HealthTech Innovation Challenge Names Nanowear as Innovation Champion

DateJan 12 2018

More than 700 startups from around the world participated in the Accenture HealthTech Innovation Challenge that culminated on January 8th at the Startup Health Festival in San Francisco—part of the 36th annual J.P. Morgan Healthcare Conference. Startups participating in the Challenge presented innovative technology and business models to help improve the way people access and manage healthcare.

IntuiTap closes $1.6M and forms strategic partnership

DateJan 11 2018

So excited to announce the close of our $1.6M round including investments from @thepinkceiling & @ionispharma! 2018 is off to a great start!

CROWDFUNDING: The 5 most successful crowdfunding campaigns in 2017

DateJan 06 2018

2017 was a banner year for crowdfunding campaigns. Here are five of the most successful crowdfunding campaigns last year that you need to know about.

Nanowear and The Secant Group announce exclusive supply chain partnership for scaled manufacturing of proprietary cloth-based nanosensor technology

DateJan 05 2018

Nanowear, the leader in cloth-based diagnostic monitoring nanosensor technology, today announced that it has entered into an exclusive, worldwide supply-chain partnership agreement with The Secant Group for scaled manufacturing and production of its medical-grade cloth-based nanosensor technology.

Miracor closes $30m Series D

DateJan 04 2018

Miracor Medical Systems said today it closed a $30.2 million (EU €25 million) round of funding as part of Series D financing round with funds slated to support further development and commercialization of its PiCSO impulse system, and announced it is moving its headquarters from Austria to Belgium.

Genomic Expression Receives $4.2M Grant to Validate Its OneRNA™ Liquid-Biopsy Platform in Bladder Cancer

DateJan 03 2018

The OneRNA4Bladder project aims to save lives and halve the cost of care for bladder-cancer treatment. Bladder cancer is the most expensive cancer to treat due to expensive diagnostic procedures and ineffective drugs resulting in a recurrence rate of 70%.